Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide

European Journal of Pharmacology

Volumn 406, Issue 3, 2000, Pages 363-374

  Di Marzo, Vincenzo ^a   Breivogel, Christopher ^b   Bisogno, Tiziana ^a   Melck, Dominique ^a   Patrick, Gray ^b   Tao, Qing ^b   Szallasi, Arpad ^c   Razdan, Raj K ^d   Martin, Billy R ^b  

^a CNR   (Italy)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^d ORGANIX INC   (United States)

Author keywords

(Mouse); Anandamide; Anti nociception; Behavior; Cannabinoid receptor; Capsaicin; Vanilloid receptor

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 5 (4 CHLOROPHENYL) 1 (2,4 DICHLOROPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; ARVANIL; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CAPSAZEPINE; N VANILLYLARACHIDONYLAMIDE; RESINIFERATOXIN; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; DRUG INHIBITION; DRUG POTENCY; HYPOTHERMIA; LIGAND BINDING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; TAIL FLICK TEST;

ANALGESICS; ANIMAL; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; BRAIN; CAPSAICIN; CHO CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCERIDES; HAMSTERS; MALE; MICE; MICE, INBRED ICR; RECEPTORS, DRUG; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034693147     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00687-7     Document Type: Article

References (49)

1. 1 receptors in mouse brain and N18TG2 neuroblastoma cells
2. Assessment of anandamide interaction with the cannabinoid brain receptor: SR141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain
3. Brain regional distribution of endocannabinoids: Implications for their biosynthesis and biological function
4. 35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity
5. The capsaicin receptor: A heat-activated ion channel in the pain pathway
6. The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication
7. The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity
8. 9-tetrahydrocannabinol
9. Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agents
10. Cannabinoid structure activity relationships: Correlation of receptor binding and in vivo activity
11. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
12. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
13. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
14. Endocannabinoids and other fatty acid derivatives with cannabimimetic properties: Biochemistry and possible physiological relevance
15. Interaction between synthetic vanilloids and the endogenous cannabinoid system
16. Cannabimimetic fatty acid derivatives: The anandamide family and other 'Endocannabinoids'
17. Cannabinoid antagonist inhibit the activation of 5-HT3 receptor in rat nodose ganglion neurons
18. Cannabinoids receptors and their endogenous agonists
19. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
20. 35S]thio)-triphosphate binding assay in rat cerebellar membranes
21. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission
22. Two new unsaturated fatty acid ethanolamines in brain that bind to cannabinoid receptor
23. The effects of a series of capsaicin analogues on nociception and body temperature in the rat
24. Intrathecal morphine in mice: A new technique
25. 2 receptors
26. Arachidonoylethanalamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes
27. Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonists 1,4-dihydropyridine binding
28. Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor
29. Behavioral, biochemical and molecular modeling evaluations of cannabinoid analogs
30. Discovery and characterization of endogenous cannabinoids
31. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds cannabinoid receptor
32. Endocannabinoids
33. 1 cannabinoid receptor
34. 1-like immunoreactivity in the central nervous system of the rat and man
35. Dihydrocapsaicin-induced hypothermia and substance P depletion
36. Pharmacology of cannabinoid receptor ligands
37. + channels
38. 1 cannabinoid receptor in cultured astrocytes
39. Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus
40. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice
41. 2-Arachidonoyl-glycerol: A possible endogenous cannabinoid receptor ligand in brain
42. 1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogue, and related compounds
43. Vanilloid (capsaicin) receptors and mechanisms
44. Identification of alpha-1-acid glycoprotein (orosomucoid) as a major vanilloid binding protein in serum
45. 1 mediates both R-type binding and C-type calcium response in dorsal ganglion neurons
46. Mesenteric vasodilation mediated by endothelial anandamide receptors
47. The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery
48. The biodisposition and metabolism in mice
49. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide